jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

June. 30, 2014

Dec. 17, 2018

jRCT2080222546

Phase 2 study to evaluate efficacy and safety of DS-8500a in patients with Type 2 Diabetes Mellitus

Phase 2 study of DS-8500a

version:
date:

DAIICHISANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html

90

Interventional

Randomized, double-blind, parallel-group study

2

Main Inclusion Criteria;
Type 2 Diabetes Mellitus

Main Exclusion Criteria;
Type 1 Diabetes Mellitus
Patients under insulin treatment
Patients with hepatic disorder
Patients with renal disorder

20age old over
69age old under

Both

Type 2 Diabetes Mellitus

investigational material(s)
Generic name etc : DS-8500a
INN of investigational material :
Therapeutic category code : 396 Antidiabetic agents
Dosage and Administration for Investigational material : Oral

24hr-weighted mean glucose

Safety, Pharmacokinetics

DAIICHISANKYO Co.,Ltd.

JapicCTI-142597

History of Changes

No Publication date
5 Dec. 17, 2018 (this page) Changes
4 April. 21, 2015 Detail Changes
3 April. 21, 2015 Detail Changes
2 June. 30, 2014 Detail Changes
1 June. 30, 2014 Detail